利索-全球专利检索

  1. Login
  2. Sign Up

Search Results

2070 records (took 0.028 seconds)

    Additive for Detoxification
    21.
    发明申请
    Additive for Detoxification 有权

    公开(公告)号：US20230139771A1

    公开(公告)日：2023-05-04

    申请号：US17912660

    申请日：2021-02-04

    Applicant: Wellington Silva

    Inventor： Wellington Silva

    IPC: A61K31/07 ,  A61K31/375 ,  A61K31/355 ,  A61K31/095 ,  A61K33/34 ,  A61K33/30 ,  A61K33/32 ,  A61K31/122 ,  A61K31/352 ,  A61K31/714 ,  A61K38/06 ,  A61K31/198 ,  A61K31/185 ,  A61K31/16 ,  A61K31/01 ,  A61K31/05

    Abstract: The present invention patent application relates essentially to an additive, the function of which is to enhance immunity, prevent various diseases and increase detoxification of the organism. The additive is composed of: 60 mcg of vitamin A; 4.5 mg of vitamin C; 1 mg of vitamin E; 3.4 mcg of selenium; 0.5 mg of copper; 0.7 mg of zinc; 0.23 mg of manganese; 3 mg of coenzyme Q10; 5 mg of pycnogenol; 0.13 mg of vitamin B2; 1.6 mg of vitamin B3; 0.13 mg of vitamin B6; 24 mcg of folic acid; 0.24 mcg of vitamin B12; 2 mg of glutathione; 100 mg of leucine; 20 mg of isoleucine; 20 mg of valine; 50 mg of glycine; 50 mg of taurine; 300 mg of glutamine; 60 mg of acetylcysteine; 50 mg of cysteine; 100 mg of methionine; 0.5 mg of vitamin B5; 2 mg of lycopene; and 4 mg of resveratrol.

    Compositions and Use of N-Chlorotaurine for Treatment and Prevention of Respiratory Infections
    27.
    发明申请
    Compositions and Use of N-Chlorotaurine for Treatment and Prevention of Respiratory Infections 有权

    公开(公告)号：US20220273594A1

    公开(公告)日：2022-09-01

    申请号：US17683197

    申请日：2022-02-28

    Applicant: Markus Nagl

    Inventor： Markus Nagl

    IPC: A61K31/185 ,  A61P31/14 ,  A61K9/00 ,  A61K9/08

    Abstract: Composition and methods for treatment or prevention of a respiratory infection in a mammal, including a viral infection, like a coronavirus such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or variants thereof. The compositions and methods include a therapeutically effective amount of about a 1% solution of N-chlorotaurine in water. The methods include administering N-chlorotaurine by nasal spray to the nostrils, by oral spray to the throat, and by nebulizer to the lungs.

    METFORMIN COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES
    29.
    发明申请
    METFORMIN COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES 有权

    公开(公告)号：US20220233574A1

    公开(公告)日：2022-07-28

    申请号：US17659537

    申请日：2022-04-18

    Applicant: William H. Cross, III

    Inventor： William H. Cross, III

    IPC: A61K31/714 ,  A61K31/185 ,  A61K31/4045 ,  A61K31/155 ,  A61P3/10 ,  A61K31/198

    Abstract: The invention provides compositions and methods to treat diabetes with improved formulations in which metformin is combined with at least three antioxidants that contain a stabilizing heteroatom adjacent to a saturated carbon and which help maintain a balance between antioxidant and pro-oxidant properties. The antioxidants include at least the combination of taurine, citrulline and methylcobalamin, and optionally include melatonin. The composition provides management of blood glucose levels comparable to metformin in the same dose without antioxidants, without the phenomenon of undermining metformin performance that is commonly observed in the presence of co-administered antioxidants.

Patent Agency Ranking